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Abstract
Background: Picrotoxin blocks GABAA receptors, whose activation typically inhibits neuronal firing activity. We
recently found that rats learn to selectively self-administer picrotoxin or bicuculline, another GABAA receptor
antagonist, into the supramammillary nucleus (SuM), a posterior hypothalamic structure localized anterior to the
ventral tegmental area. Other drugs such as nicotine or the excitatory amino acid AMPA are also self-administered
into the SuM. The SuM appears to be functionally linked with the mesolimbic dopamine system and is closely
connected with other brain structures that are implicated in motivational processes, including the prefrontal cortex,
septal area, preoptic area, lateral hypothalamic area and dorsal raphe nucleus. Here, we hypothesized that these
brain structures are activated by picrotoxin injections into the SuM.
Results: Picrotoxin administration into the SuM markedly facilitated locomotion and rearing. Further, it increased c-
Fos expression in this region, suggesting blockade of tonic inhibition and thus the disinhibition of local neurons.
This manipulation also increased c-Fos expression in structures including the ventral tegmental area, medial shell of
the nucleus accumbens, medial prefrontal cortex, septal area, preoptic area, lateral hypothalamic area and dorsal
raphe nucleus.
Conclusions: Picrotoxin administration into the SuM appears to disinhibit local neurons and recruits activation of
brain structures associated with motivational processes, including the mesolimbic dopamine system, prefrontal
cortex, septal area, preoptic area, lateral hypothalamic area and dorsal raphe nucleus. These regions may be
involved in mediating positive motivational effects triggered by intra-SuM picrotoxin.
Background
Recent intracranial self-administration studies have
helped to define key brain structures involved in positive
motivational processes involved in approach/seeking [1].
One such structure is the supramammillary nucleus
(SuM), located in the posterior hypothalamic area, just
dorsal to the mammillary body and anterior to the ven-
tral tegmental area (VTA). The SuM was initially impli-
cated in reward-related processes by the finding that
rats learn instrumental responses to obtain brief electri-
cal stimulation in the vicinity of the SuM [2]. We
recently found that rats readily learn to lever-press for
infusions of GABAA receptor antagonists, picrotoxin or
bicuculline [3], the excitatory amino acid AMPA [4], or
nicotine [5] into the SuM, suggesting that activation of
supramammillary neurons recruits approach-related
motivational processes [1].
We have also shown low systemic doses of dopamine
receptor antagonists decrease rats’ self-administration of
picrotoxin or AMPA into the SuM [3,4]. These findings
suggest that motivational effects of supramammillary
manipulations depend on intact dopamine transmission.
In addition, AMPA administration into the SuM
increases extracellular dopamine concentrations in the
ventral striatum as measured by microdialysis [4]. This
result suggests that activation of supramammillary
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dopamine system.
Conversely, some manipulations that activate VTA
dopamine neurons appear to activate supramammillary
neurons. One manipulation that supports robust self-
administration is the cholinergic receptor agonist carba-
chol into the posterior VTA [6], which increases extra-
cellular dopamine in the ventral striatum [7], suggesting
that this manipulation activates the mesolimbic dopa-
mine system. The administration of carbachol into the
posterior VTA was found to robustly increase the tran-
scription factor c-Fos in the SuM [8]. SuM c-Fos counts
were positively correlated with locomotor counts
increased by carbachol administration into the VTA,
suggesting that SuM neurons participate in motivational
effects triggered by posterior VTA activation. These
findings suggest that supramammillary neurons interact
with the mesolimbic dopamine system.
Although the SuM appears to be functionally linked
with the dopaminergic projection from the VTA to the
ventral striatum, connectivity between the SuM and
these regions is either absent or scarce [9-14]. Addi-
tional connectivity analysis suggests that several regions
that are reciprocally connected with the SuM are also
reciprocally connected with the VTA [1]. These include
the medial prefrontal cortex, septal area, preoptic area,
lateral hypothalamic area and dorsal raphe nucleus.
Moreover, these efferent and afferent regions of the
SuM and VTA appear to be closely interlinked. Because
these regions have also been implicated in reward-
related processes, these brain regions, the mesolimbic
dopamine system and SuM may constitute a network
module that mediates approach-related motivational
processes [1].
Using c-Fos as a marker for neuronal activation, we
sought to address the following hypotheses: 1) the
administration of GABAA receptor antagonist picrotoxin
into the SuM activates its’ local neurons, because the
GABAA receptor antagonist blocks tonic inhibition,
leading to neuronal disinhibition; 2) picrotoxin adminis-
tration into the SuM activates the mesolimbic dopamine
system; 3) picrotoxin administration into the SuM acti-
vates the brain regions that are involved in motivational
processes and reciprocally connected with both SuM
and VTA: medial prefrontal cortex, septum, preoptic
area, lateral hypothalamic area, and dorsal raphe
nucleus.
In addition, we examined whether intra-SuM adminis-
tration of picrotoxin facilitates locomotor activity. Posi-
tive motivational manipulations such as brain
stimulation reward and drugs of abuse are known to
acutely facilitate locomotor activity in rats [15,16].
Because our previous studies show positive motivational
effects of intra-SuM picrotoxin, we hypothesized that
this manipulation will facilitate locomotor activity in
open fields. The present study focused on effects of
acute intra-SuM picrotoxin administration on locomotor
activity and c-Fos expressions in reward-related brain
structures. Therefore, the study emphasized on initial
unconditioned processes, rather than conditioned pro-
cesses, triggered by SuM manipulations.
Results and Discussion
Each rat unilaterally received picrotoxin or vehicle into
the vicinity of the SuM through a permanent guide can-
nula. After a locomotor activity test, each rat was killed
for histological processes of c-Fos expression and
cannula placement. Each rat’s cannula placement was
verified with microscopic examination and shown in
Figure 1.
Effects of SuM picrotoxin administration on locomotor
activity
Unilateral administration of picrotoxin (0.3 mM in 0.3
μl) into the SuM immediately facilitated locomotion and
rearing that then gradually decreased over the next 40
min (Figure 2). Because rats that received artificial cere-
brospinal fluid into regions just outside the SuM showed
similar locomotor/rearing counts as those receiving it
into the SuM, the data of both groups were combined
together as vehicle control data. During the 60 min
observation period, the rats that received picrotoxin into
the SuM traveled and reared approximately 4 times
more than those that received vehicle. These observa-
tions were verified by mixed 3 × 12 (injection manipula-
tion group × 5-min block) ANOVA/MANOVAs. We
found significant group × block interactions, F22,34 =
2.72, P = 0.0042 for locomotion and F22,34 = 2.31, P =
0.013 for rearing. These results suggest that picrotoxin
injections into the SuM markedly facilitate locomotion
and rearing. Because the SuM is closely connected with
visceral and affective processing structures rather than
motor processing structures and because previous stu-
dies suggest positive motivational role of this structure,
it is tempting to suggest that locomotor activity
triggered by intra-SuM picrotoxin is secondarily
facilitated through motivational processes, thereby
reflecting unconditioned motivational processes of the
manipulation.
Effects of SuM picrotoxin administration on c-Fos in
reward related structures
Figures 3, 4, 5 show c-Fos expression from the level of
the prefrontal cortex to the level of midbrain raphe
nuclei of representative rats. We also quantified c-Fos in
selected brain regions (Figure 6) and summarized data
in Table 1. Consistent with our hypothesis that picro-
toxin administration into the SuM disinhibits its local
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Page 2 of 13neurons, we observed robust c-Fos expression in the
SuM after picrotoxin administration into the region
(Figures 5A and 7). These findings fit with our previous
interpretation that self-administration and conditioned
place preference induced by intra-SuM AMPA or picro-
toxin are mediated by the excitation of local neurons
[3,4].
We observed the pattern of c-Fos expression in the
VTA and the ventral striatum paralleled with the con-
nectivity between the VTA and ventral striatum. The
posterior but not anterolateral VTA had reliable
increases in c-Fos expression after intra-SuM picrotoxin,
while the medial nucleus accumbens shell had more
reliable increases in c-Fos counts than the accumbens
core (Figure 5B; Table 1). These results parallel the pro-
jection pattern of dopaminergic neurons from the VTA
to the ventral striatum. The posterior VTA has been
shown to predominantly project to the medial part of
the ventral striatum, including the medial shell, while
the anterolateral VTA largely projects to the lateral part
of the ventral striatum, including the core [17]. In other
words, there is mediolateral topography for dopaminer-
gic neurons projecting from the VTA (posterior-antero-
lateral) to the ventral striatum (medial-lateral). This
congruence between c-Fos and structure suggests that
SuM picrotoxin activates the medial part of the meso-
limbic dopamine system more reliably than the lateral
part, and that the SuM is functionally linked with the
medial mesolimbic dopamine system more closely than
its’ lateral counterpart. Because the medial mesolimbic
dopamine system appears to mediate drugs’ motivational
effects more readily than the lateral portion of the sys-
tem [17,18], these findings are consistent with our
hypothesis that the mesolimbic dopamine system and
the SuM interact for approach-related motivational
processes.
In addition to the medial mesolimbic dopamine sys-
tem, we observed increased expression of c-Fos in other
regions that are closely connected with both the SuM
and VTA. Picrotoxin administration into the SuM
increased c-Fos expression in the septal complex, espe-
cially the intermediate and ventral parts of the lateral
septal nucleus, the medial prefrontal cortex, the lateral
preoptic area, the lateral hypothalamic area and the dor-
sal raphe nucleus. These regions, which are closely con-
nected with both the SuM and VTA and expressed
picrotoxin-induced c-Fos, have been previously impli-
cated in positive motivational processes. Rats learn to
self-stimulate these regions with brief electrical current
[2,19-21]. Injections of drugs into these regions are
Figure 1 Locations of the tips of injection cannulae. Injection
sites found within the supramammillary nucleus are marked by red
rectangles (N = 14). Blue rectangles indicate injection sites outside
the supramammillary nucleus (N = 7) and gray indicate vehicle
injection sites (N = 9).
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Page 3 of 13rewarding, including cocaine [22] and NMDA receptor
antagonists [23] in the medial prefrontal cortex, mor-
phine and muscimol in the septal area [24-26], mor-
phine in the lateral hypothalamic area [27,28], and the
GABAA receptor agonist muscimol and GABAB receptor
a g o n i s tb a c l o f e ni nt h ed o r s a lr a p h en u c l e u s[ 2 9 , 3 0 ] .
Picrotoxin administration into the SuM tended to
increase, without a statistical significance, c-Fos in the
medial preoptic nucleus, which is implicated in drug
reward [31,32]. The same manipulation significantly
increased c-Fos expression in the lateral preoptic
nucleus, which supports self-stimulation [33], but has
not previously been implicate in drug reward. Because
the preoptic nuclei are closely connected with the SuM,
VTA and the above-mentioned regions that showed sig-
nificant c-Fos expression, these nuclei could play an
important role in motivational processes initiated
through the SuM. Thus, these findings generally support
our hypothesis that these brain structures participate in
motivational processes mediated through the SuM.
c-Fos expression following brain stimulation reward
We mentioned in the background section that carbachol
administration into the posterior VTA increases c-Fos
expression in the SuM. Similarly, increased c-Fos
expression has been found in the SuM and other brain
structures that we reported here following rewarding
electrical stimulation delivered at the lateral hypothala-
m i ca r e a[ 3 4 ]a sw e l la sv i c i n i t yo ft h ed o r s a lr a p h e
nucleus [35]. These previous and present findings are
consistent, though not unequivocally, with the view that
the SuM is a component of a network module mediat-
ing approach-type motivational processes [1].
Limitations
To avoid interpreting the results beyond what they are,
it is important to acknowledge limitations of our c-Fos
technique. c-Fos expression is a correlate of manipula-
tions and thus does not indicate any causal relationship.
Accordingly, the technique cannot discriminate between
reward-related neurons and other activated neurons.
Thus, c-Fos expression does not necessarily mean invol-
vement in positive motivational processes. Furthermore,
c-Fos may not necessarily be expressed in every acti-
vated cell. Thus, the absenceo fc - F o sd o e sn o ti n d i c a t e
the absence of neuronal activation. Finally, temporal
resolution of the technique is poor. Therefore, the tech-
nique does not show how neurons were activated. In
particular, our observations suggest that c-Fos expres-
sion can result from first-, second- or even third-order
trans-synaptic activation. Ipsilateral sides of regions that
receive monosynaptic efferents from picrotoxin-affected
part of the SuM tended to have more c-Fos expression
than the contralateral sides of bilateral structures,
including the medial prefrontal cortex, lateral septal
area, diagonal band of Broca, preoptic areas and lateral
hypothalamic area (Table 1). However, c-Fos expression
was generally observed bilaterally throughout the brain,
Figure 2 Locomotor and rearing counts in open-field chambers after microinjections of picrotoxin or vehicle into the vicinity of the
supramammillary nucleus. Left and right panels show mean locomotion and rearing, respectively, as a function of injection manipulation
group and time. * P < 0.05, significantly greater than respective vehicle value. Abbreviations: Picro, picrotoxin; OUT, outside of the SuM.
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Page 4 of 13Figure 3 c-Fos expression in forebrain sections of representative rats after injections of picrotoxin or vehicle into the SuM.E a c hr e d
dot indicates a nucleus containing c-Fos. Abbreviations: AcbC, nucleus accumbens core; AcbSh; nucleus accumbens shell, medial part; BST, bed
nucleus of stria terminalis; Cg, cingulate cortex; LSD, lateral septal nucleus, dorsal part; LSI, lateral septal nucleus, intermediate part; LSV, lateral
septal nucleus, ventral part; MS, medial septal nucleus; Pir, piriform cortex; PrL, prelimbic cortex; Tu, olfactory tubercle; VDB, nucleus of the vertical
limb of the diagonal band.
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Page 5 of 13Figure 4 c-Fos expression at the level of hypothalamus of representative rats after injections of picrotoxin or vehicle into the SuM.
Abbreviations: BLA, basolateral amygdaloid nucleus; Ce, central amygdaloid nucleus; CM, central medial thalamic nucleus; DG, dentate gyrus of
hippocampus; LPO, lateral preoptic nucleus; MPA, medial preoptic nucleus; Pa paraventricular hypothalamic nucleus; PLH, peduncular part of
lateral hypothalamus; Pir, piriform cortex; PT, paratenial thalamic nucleus; PV, paraventricular thalamic nucleus; Re, reuniens thalamic nucleus;
RSGc, rostrosplenial granular cortex, c region.
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Page 6 of 13Figure 5 c-Fos expression in brainstem sections of representative rats after injections of picrotoxin or vehicle into the SuM.
Abbreviations: DR, dorsal raphe nucleus; IC, inferior colliculus; IP, interpeduncular nucleus; MnR, median raphe nucleus; PAG, periaqueductal gray;
Pn, pontine nuclei; SC, superior colliculus; SuM, supramammillary nucleus; VTAp, posterior ventral tegmental area; VTg, ventral tegmental nucleus
of Gudden.
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Page 7 of 13including regions that do not receive efferents from the
SuM (Figures 3, 4 and 5).
Conclusion
Administration of the GABAA receptor antagonist picro-
toxin into the SuM, which was previously found to
recruit positive motivational processes related to
approach/seeking, facilitated locomotor activity and
induced c-Fos expression in extensive brain structures.
The patterns of c-Fos expression suggest that it disinhi-
bits local neurons and recruits activation of the meso-
limbic dopamine system, prefrontal cortex, septal area,
preoptic area, lateral hypothalamic area and dorsal
raphe nucleus. These brain structures may be involved
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Figure 6 Areas of c-Fos counts. c-Fos expression was measured in 325 × 425 μm rectangles (shown in red) placed in respective regions of
coronal sections [36]. The numbers indicate distances from bregma. Abbreviations: AcbC, nucleus accumbens core; AcbSh; nucleus accumbens
shell, medial part; BLA, basolateral amygdaloid nucleus; Ce, central amygdaloid nucleus; CLi, central (caudal) linear nucleus; CM, central medial
thalamic nucleus; DMD dorsomedial hypothalamic nucleus, dorsal part; DG, dentate gyrus of hippocampus; DR, dorsal raphe nucleus; HDB,
nucleus of the horizontal limb of the diagonal band; LHb, lateral habenula nucleus; LPO, lateral preoptic nucleus; LSD, lateral septal nucleus,
dorsal part; LSI, lateral septal nucleus, intermediate part; LSV, lateral septal nucleus, ventral part; MnR, median raphe nucleus; MPA, medial
preoptic nucleus; MS, medial septal nucleus; PLH, peduncular part of lateral hypothalamus; PrL, prelimbic cortex; PV, paraventricular thalamic
nucleus; RSGc, rostrosplenial granular cortex, c region; Shy, septohypothalamic nucleus; SuM, supramammillary nucleus; Tu, olfactory tubercle;
VDB, nucleus of the vertical limb of the diagonal band; VTAa, anterolateral ventral tegmental area; VTAp, posterior ventral tegmental area.
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Page 8 of 13Table 1 c-Fos counts in reward-related regions following an injection of either vehicle or picrotoxin into the SuM or
its vicinity
c-Fos counts in a 325 × 425 μm area
Region PIC-SUM
(N = 14)
PIC-OUT
(N = 7)
VEH
(N = 9)
Distance (mm) Hemi-sphere Mean P-value Mean P-value Mean
Cortex Medial prefrontal cortex 2.8 i 71.4 0.0042 40.7 0.2695 26.3
2.8 c 60.2 0.0399 30.6 0.8129 27.7
Retrosplenial granular cortex -2.8 i 50.2 0.0572 45.4 0.0402 5.7
-2.8 c 35.8 32.7 8.4
Hippocampus dentate gyrus -2.8 i 44.1 14.4 1.6
-2.8 c 41.3 7.9 1.9
Basolateral nucleus of amygdala -2.8 i 11.8 18.3 3.3
-2.8 c 12.9 17.3 4.6
Basal forebrain Central nucleus of amygdala -2.8 i 6.6 33.1 8.2
-2.8 c 6.9 7.0 6.2
Lateral septal nucleus, dorsal part 2.0 i 43.7 0.0565 56.3 0.0263 11.4
2.0 c 38.7 41.1 12.2
1.0 i 13.0 24.1 1.6
1.0 c 10.3 22.3 1.6
0.0 i 18.4 0.0261 6.4 0.4434 1.8
0.0 c 17.4 0.0369 10.6 0.1427 1.3
Lateral septal nucleus, intermediate part 2.0 i 72.9 0.0009 16.6 0.5070 5.8
2.0 c 43.9 0.0016 13.4 0.5993 8.7
1.0 i 194.1 0.0004 74.4 0.1148 7.7
1.0 c 99.9 0.0045 35.4 0.3642 12.4
0.0 i 57.1 0.0084 26.1 0.1900 4.3
0.0 c 45.3 0.0086 17.0 0.3078 3.7
Lateral septal nucleus, ventral part 2.0 i 150.1 0.0009 76.9 0.0730 18.0
2.0 c 86.3 0.0084 57.0 0.0887 22.2
1.0 i 297.4 0.0002 102.9 0.1898 32.3
1.0 c 158.1 0.0017 52.6 0.6105 36.6
0.0 i 139.6 0.0031 96.9 0.0205 8.6
0.0 c 81.1 0.0065 61.4 0.0202 6.9
Septohypothalamic nucleus 0.0 i 127.1 0.0009 55.6 0.1279 12.0
0.0 c 73.0 0.0144 54.9 0.0423 11.7
Medial septal nucleus 1.0 i 17.2 10.4 6.4
0.0 c 18.9 0.0136 14.7 0.0290 1.7
Nucleus of the vertical limb of the diagonal band 1.0 i 21.9 0.0356 10.0 0.2844 1.6
1.0 c 6.2 10.1 1.1
Nucleus of the horizontal limb of the diagonal band 1.0 i 19.0 0.0097 11.6 0.0778 1.6
1.0 c 4.3 6.1 1.7
Nucleus accumbens core 2.0 i 31.4 4.6 2.9
2.0 c 25.9 0.0434 2.0 0.8836 3.6
1.0 i 12.6 3.4 2.1
1.0 c 9.6 3.4 2.8
Nucleus accumbens shell, medial part 2.0 i 48.2 0.0012 7.1 0.8499 5.1
2.0 c 43.8 0.0022 10.6 0.6573 6.1
1.0 i 23.4 0.0202 12.9 0.1577 2.4
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activation of supramammillary neurons.
Methods
Animals
Thirty male Wistar rats (Harlan, Dublin, VA, USA)
weighing 250-350 g at the time of surgery were used
in this experiment. They were initially housed in pairs,
and after surgery, were housed individually in a
humidity controlled room kept at a constant tempera-
ture and on a reverse 12-h light-dark cycle (lights on
at 9:00 PM). Food and water were freely available
except during testing. All procedures were approved by
the Animal Care and Use Committee of the National
Institute on Drug Abuse Intramural Research Program
and were in accordance with the National Institutes of
Health guidelines.
Surgery
Under sodium pentobarbital (31 mg/kg, i.p.) and
chloral hydrate (142 mg/kg, i.p.) anesthesia, rats were
implanted unilaterally with a single guide cannula (24
gauge, Plastics One, VA, USA) into the left hemisphere
that ended 1.0 mm rostral and dorsal to the supra-
mammillary nucleus. While the injection cannula,
which extended 1.0 mm beyond the tip of the guide,
was not in use, a 28 gauge dummy stylet maintained
the patency of the guide cannula, which extended 0.5
mm beyond the tip of the guide. Using a digital stereo-
taxic instrument, the following target coordinates (in
millimeters) were measured: 3.8 - 4.3 posterior to
bregma, 0.5 lateral to the midline, and 8.4 ventral to
t h es k u l ls u r f a c e .T h ec a n n u l a ew e r ei n s e r t e da ta3 0 °
on the rostrocaudal plain from a rostral-to-caudal
direction and a 7° on the mediolateral plain from a
Table 1 c-Fos counts in reward-related regions following an injection of either vehicle or picrotoxin into the SuM or
its vicinity (Continued)
1.0 c 18.6 0.0361 8.4 0.3962 3.4
Olfactory tubercle 2.0 i 7.4 5.9 1.3
2.0 c 6.4 12.0 1.9
Thalamus Paraventricular thalamic nucleus -1.0 i 50.2 29.4 39.2
-1.0 c 41.4 29.9 36.0
-2.0 m 72.1 79.4 76.1
Central medial thalamic n -2.0 m 43.6 45.4 31.1
Lateral habenula -3.0 i 18.7 18.9 18.2
-3.0 c 47.1 0.0494 24.0 0.4813 14.7
Hypothalamus Medial preoptic area 0.0 i 34.1 15.7 9.8
0.0 c 18.6 12.1 11.3
Lateral preoptic area 0.0 i 45.5 0.0313 50.3 0.0422 7.3
0.0 c 30.0 37.6 8.1
-1.0 i 35.3 0.0118 39.9 0.0120 2.2
-1.0 c 19.7 0.0083 35.9 0.0001 2.4
Dorsomedial hypothalamic nucleus -3.0 i 47.7 0.0042 6.9 0.6072 12.7
-3.0 c 36.6 0.0826 7.4 0.4753 15.8
Lateral hypothalamic area -2.0 i 30.1 0.0120 22.0 0.0444 4.9
-2.0 c 20.0 0.0166 23.1 0.0131 4.3
Supramammillary n -4.0 m 187.0 0.0021 141.0 0.0170 48.3
Midbrain Anterolateral VTA -5.0 i 23.1 0.0603 4.9 0.7089 1.4
-5.0 c 1.8 1.9 1.6
Posterior VTA -5.8 i 9.6 0.0135 4.1 0.2728 1.0
-5.8 c 3.7 3.6 1.0
Central linear n -6.7 m 3.9 3.6 1.0
Dorsal raphe n -7.8 m 21.1 0.0251 16.0 0.0498 1.7
Median raphe n -7.8 m 15.4 20.1 1.3
Notes: c-Fos counts in bold indicate significant differences from respective counts for vehicle injections. Blank space in the p-value columns indicates that the
effect of region was not significant, following an ANOVA/MANOVA test. Abbreviations: c, contralateral to injection site; i, ipsilateral to injection site; m, midline; n,
nucleus
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Page 10 of 13periphery-to-midline direction. This angular position-
ing of the cannulae was used to minimize tissue
destruction when brains were cut for coronal sections,
particularly at the level of injection site. If cannulae
had been placed vertically from the dorsal entry just
above the injection site, coronal sections at the level of
the injection site would have been easily damaged due
to the cannula track, which would have hindered c-Fos
counts and our ability to locate the injection site. All
depth measurements were made from the skull surface
with the incisor bar set at 3.3 mm below the interaural
line. The cannulae were subsequently anchored to the
skull with 4 screws and dental acrylic. Animals were
allowed 3 postsurgical recovery days, before we started
daily handling for 2 minutes over 3 consecutive days
in experimental room.
Figure 7 Photomicrographs showing representative injection sites in coronal sections at the level of the supramammillary nucleus.
Arrows indicate the tips of injection cannulae for injections of picrotoxin (A) and vehicle (B). Abbreviations: fr, fascicular retroflexus; ml, medial
lemniscus; pm, principal mammillary tract.
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The GABAA antagonist, picrotoxin (Sigma, St. Louis,
MO) was dissolved in artificial cerebrospinal fluid con-
sisting of (in mM): 148 NaCl, 2.7 KCl, 1.2 CaCl2,a n d
0.85 MgCl2, pH adjusted to 6.5-7.8.
Drug administration and behavioral monitoring
Each rat was individually placed in a Plexiglas locomotor
chamber (40 × 40 × 30 cm; AccuScan Instrument,
Columbus, OH) equipped with infrared detectors to
record horizontal distance traveled and frequency of
vertical movements (a measure of rearing incidents) for
2 hours per day for 7 consecutive days. On days 1-5,
after 60 min in the locomotor chamber, each rat was
allowed to become accustomed to handling procedures
for microinjection without actual injections. The rat was
placed in a cylinder (30 cm in diameter) for 2 min and
returned to the locomotor chamber. On day 6, after the
first 60 min in the locomotor chamber, each rat was
placed in the cylinder, and its dummy stylet was
removed and replaced with an injection cannula (31
gauge) attached to polyethylene tubing via a 10 μl
Hamilton gas tight syringe controlled by a Harvard
pump (model 22). The rat received vehicle (300 nl) over
60 sec, followed by additional 30 sec before the injection
cannula was removed. Immediately after the dummy sty-
let was placed, the rat was returned to the locomotor
chamber for additional 60 min. On day 7, rats received
either 0.3 mM picrotoxin or vehicle with the procedure
described above.
Histology
Ninety minutes following microinjections of picrotoxin
or vehicle, rats were given sodium pentobarbital (31 mg/
kg, i.p.) and chloral hydrate (142 mg/kg, i.p.) anesthesia
and perfused intracardially with 0.9% saline with 0.2%
sodium nitrite solution followed by a 4% paraformalde-
hyde solution. Their brains were then removed and
placed in 4% paraformaldehyde solution for 4 h before
being transferred to a mixture of 18% sucrose and 2%
paraformaldehye fixative for another 2 days prior to sec-
tioning. Using a cryostat, frozen coronal sections, taken
at 40 μm from the level of the prefrontal cortex to the
level of the caudal pontine reticular nucleus, were sub-
merged in phosphate buffer saline (PBS) and subse-
quently processed for c-Fos immunoreactivity described
below. One of five consecutive sections was taken for
processing. Boundaries of the SuM and other brain
regions as defined by the atlas of the Paxinos and Wat-
son [36] were determined on the basis of cytoarchitec-
tonic features of each section. If a cannula’s 0.3 mm tip
was not found within the SuM, it was considered out-
side this structure.
Immunohistochemical procedure
After washing in PBS, sections were incubated in 0.3%
hydrogen peroxide for 10 min followed by 3 × 10 min
rinses with PBS. Sections were subsequently treated
with normal goat serum (Vector Laboratories, Burlin-
game, CA) with 0.25% Triton X-100 in PBS for 2 h.
They were then incubated overnight at 4°C with anti-c-
Fos rabbit antibody (1:1000, Santa Cruz Biotechnology,
Santa Cruz, CA) diluted in PBS containing 0.25% Triton
X-100. After rinsing 4 × 15 min in PBS, sections were
incubated in a 1:200 dilution of the biotinylated second-
ary antibody for 2 h. After 3 × 10 min rinses with PBS,
samples were treated with avidin-biotinylated enzyme
complex (Vector Laboratories) for 1 h. Samples were
then rinsed with PBS for 2 × 10 min and subjected to a
0.05% 3,3-diaminobenzidine-4 HCl (DAB) and 0.003%
hydrogen peroxide (H2O2) solution followed by final 3 ×
10 min rinses with PBS. Sections were subsequently
mounted on gelatin coated slides and air-dried over-
night. All sections were then incubated with Methyl
Green (Vector Laboratories) for 10 min for
counterstaining.
Quantification and visualization of c-Fos
c-Fos was quantified under light microscopic examina-
t i o nw i t ha2 0 ×o b j e c t i v eu s i ng imaging software (NIS
Elements, v2.1, Nikon Instruments, Melville, NY). The
sampling area was 325 × 425 μm with a 300 minimum
and 3000 maximum detection threshold. We chose
brain regions (Figure 6) that have been implicated in
drug reward or are major projection targets of the
supramammillary nucleus. c-Fos counts were recorded
from brain regions of both hemispheres. In addition, we
examined coronal sections of two representative brains
receiving picrotoxin and vehicle for c-Fos expression
throughout the brain, using a Nikon 80i light micro-
scope equipped with a 10× objective and motorized-
stage controlled by Neurolucida (MBF Bioscience, Will-
iston, VT).
Statistical Analyses
Data were analyzed with the ANOVA/MANOVA module
of Statistica (version 6.1, StatSoft, Inc., Tulsa, OK). When
the sphericity assumption examined by Mauchley Spheri-
city Test was violated for repeated factors, effects of the
repeated factors were analyzed by MANOVAs; otherwise
ANOVAs were used. When factors with more than two
levels were found to be significant, we performed New-
man-Keuls posthoc tests. Pearson’s product-moment cor-
relation coefficients were calculated between c-Fos counts
and locomotion or rearing scores (during the first 30 min)
among all the rats including rats received picrotoxin out-
side of the SuM and vehicle (N = 30).
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